Solio Therapy

What Solio Therapy does

Solio Therapy, legally DMT LTD, is an Israeli medical device company founded in 2019 and headquartered in Givat Ada, Israel. The company designs, manufactures, and sells the Solio Alfa Plus, an FDA-cleared home-use pain relief device built around its patented "3-E Technology." This system combines three energy modalities—Bi-polar Radiofrequency (RF), Infrared (IR) heat energy, and Low Light Laser Therapy (LLLT)—delivered through a single handheld unit that penetrates 11-30mm into tissue and produces localized heat up to 44°C (111°F). The architecture is positioned as the first RF-based pain management device to receive FDA clearance for home use, with claimed performance advantages of 25mm penetration depth and 24W power output versus competing light-only devices.

The product portfolio centers on the Solio Alfa Plus at $475 and its companion Slider Gel consumable, supplemented by a small line of related accessory devices: the Solio Super Gun Massager 2.0, the Solio Lumbar Back Stretcher, and the Back Shoulder Posture Corrector. Solio Therapy operates as a pure-play direct-to-consumer brand, with all sales fulfilled through its e-commerce website (soliotherapy.com) and customer support provided via a US phone number and email. Customer acquisition is driven by SEO-optimized educational content covering more than 20 pain conditions, comparison pages against competitors (Tendlite, Omron, Quell), doctor testimonials, and verified customer reviews.

The company targets a horizontal set of use-case segments: chronic pain sufferers, athletes and sports enthusiasts, trauma-related pain patients, women with menstrual pain, and post-surgery recovery patients. Endorsements from board-certified dermatologists and plastic surgeons (Stephen Mulholland MD, Tina S. Alster MD, Judith Hellman MD) and professional athletes (Dudi Sela, Hanna Kneibze-Minnko) are used as credibility signals. The business appears bootstrapped with no disclosed funding rounds, no management team listed, and a headcount range of 1-10 employees. Product fulfillment is international across the USA, Canada, the UK, and Israel, but no retail, wholesale, or third-party distribution channels are utilized.

Name

Solio Therapy

Legal name

DMT LTD

Website

https://soliotherapy.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Solio Therapy (DMT LTD) is an Israeli direct-to-consumer company that designs, manufactures, and sells the FDA-cleared Solio Alfa Plus pain relief device, which combines Radiofrequency, Infrared, and Low Light Laser Therapy in a patented 3-E system for at-home chronic and acute pain treatment.

Ownership category

akta.pro rank

Product category

Pain Relief Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Infrared Therapy (Infrared Sauna & Light Therapy) (HSADAKAG)

Keywords

• Pain relief devices
• Home medical devices
• Light therapy products
• FDA cleared devices
• Therapeutic massagers

Headquarters

HQ city

Herzliya

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. Solio Alfa Plus Device Sales: One-time purchase of the main pain relief device at $475, including 2-year warranty. The device is sold directly to consumers through the company's e-commerce platform.
2. Consumables and Accessories: Ongoing sales of Slider Gel and potentially other accessories required for device operation. Gel is not covered under warranty and needs periodic replacement.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Solio Therapy designs, manufactures and sells FDA-cleared home-use pain relief medical devices. Its flagship Solio Alfa Plus device uses a patented 3-E Technology combining Bi-polar Radiofrequency (RF), Infrared (IR) heat energy, and Low Light Laser Therapy (LLLT) to penetrate 11-30mm into tissue. The company sells directly to consumers through its e-commerce website, offering the main device, Slider Gel consumable, and complementary devices (massager, back stretcher, posture corrector).

Product overview

Solio Therapy offers a portfolio of home-use medical devices for pain relief, centered on the Solio Alfa Plus device. The core product combines three energy technologies (Bi-polar RF, Infrared, and LLLT) in a patented 3-E system. The product ecosystem includes the main Solio Alfa Plus unit, a companion Slider Gel for enhanced conductivity, and related products such as the Solio Super Gun Massager, Lumbar Back Stretcher, and Back Shoulder Posture Corrector.

Differentiator

Problem solved

Functional benefit

Brands

• Solio Alfa Plus: Main pain relief device utilizing 3-E technology (RF, IR, LLLT) for chronic pain treatment. FDA-cleared.
• Solio Super Gun Massager 2.0
• Solio Lumbar Back Stretcher
• Back Shoulder Posture Corrector
• Slider Gel

Products and services

• Solio Alfa Plus Pain Relief Device FDA-cleared home-use pain relief device that combines Bi-polar Radiofrequency (RF), Infrared (IR) heat energy, and Low Light Laser Therapy (LLLT) in a patented 3-E Technology. Penetrates 11-30mm into tissue, produces heat up to 44°C, and is sold to consumers seeking non-invasive, drug-free treatment for chronic and acute pain conditions.
• Solio Alfa Plus Slider Gel Transparent, fragrance-free conductive gel applied to the Solio Alfa Plus device before treatment to enhance energy transfer into the skin during RF and light therapy sessions. Required consumable for device operation, not covered under warranty.
• Solio Super Gun Massager 2.0 Massager device for pain relief and muscle relaxation, sold as a related product alongside the main Solio Alfa Plus pain relief device.
• Solio Lumbar Back Stretcher Back stretching device designed to help relieve lower back pain and improve posture, sold alongside the main Solio pain relief products.
• Back Shoulder Posture Corrector by Solio Posture correction device designed to support shoulders and improve back alignment, offered as a complementary product to the main Solio pain relief device.

Quantifiable outcome

• Pain relief typically begins after 4-7 treatments for neck/cervical areas
• +3 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Quell (NeuroMetrix): Direct competitor in the FDA-cleared, wearable/home-use pain relief device category. Solio publishes a head-to-head comparison article, indicating close product overlap with chronic pain sufferers as the shared target buyer.
• iReliev: Consumer-focused TENS/EMS pain relief device brand competing in the same online retail and Amazon channels. Overlapping customer segments (chronic pain, athletes, post-recovery).
• HiDow: Direct-to-consumer maker of TENS/EMS and combined-modality pain relief devices sold online at consumer price points. Closely matches Solio's DTC motion and target customer profile.
• Tendlite: Direct competitor in the consumer at-home light therapy (LLLT) pain relief market. Solio explicitly benchmarks against Tendlite on penetration depth and power, making it the closest like-for-like comparison.

Broad incumbents

• BTL Industries: Established player in professional and consumer electromedical/electrotherapeutic devices, including RF-based pain and aesthetic platforms. Comparable use of RF and light-based energy for musculoskeletal and pain indications.
• Compex (DJO/Enovis): Well-known neuromuscular electrical stimulation (NMES) brand for pain relief, recovery, and training. Comparable modality (electrostimulation) and overlapping users in sports medicine and physical therapy.
• Chattanooga (DJO/Enovis): Professional-grade electromedical and rehabilitation equipment maker supplying physical therapy and pain clinics. Analogous to a clinical/professional channel Solio could target as its next expansion vector.
• Omron Healthcare (TENS devices): Major incumbent in consumer pain management with widely distributed TENS units. Solio positions itself against Omron on technology depth; overlapping end customers and retail channels make it a broad competitor.

Emerging players

• Pure Enrichment: DTC wellness brand with broader pain-relief and massager portfolio. Overlaps with Solio's adjacent products (massager, lumbar stretcher) and shares the e-commerce-first GTM motion.
• Theragun (Therabody): Premium consumer percussive therapy and recovery brand. Competes for the same discretionary consumer spend on at-home pain and recovery, with strong DTC and retail presence.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/SolioTherapy

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Solio Therapy